100 relevant articles · classified by Haiku 4.5 · ingested daily
Democratic lawmakers plan investigations into major healthcare topics if they win congressional majorities in November.
PureTech Health spinout Celea Therapeutics raises $180M for Phase 3 trial of pulmonary fibrosis drug deupirfenidone.
Aurenar's V-Link ear-based nerve stimulation device wins FDA breakthrough designation after reducing cerebral vasospasm by over 40% in early trials.
ONC reports fewer health information exchanges experiencing information blocking, though some may block more frequently.
An analysis of how agentic AI could evolve beyond answering questions to actively handle healthcare administrative tasks like insurance coordination and prescription management.
Evernorth commits $100M through 2028 to Pharmacy Forward, an AI program for specialty pharmacy operations.
ONC awards a contract to oversee TEFCA compliance as health record exchanges through the framework exceed 1 billion.
HHS solicits healthcare sector input on AI governance and coordination across federal agencies.
Abridge's AI documentation tool reduced after-shift charting by up to 45 minutes and cut RN vacancy rates more than in half at Reid Health.
Aidoc receives FDA Breakthrough Device designation for an AI tool that analyzes chest X-rays and generates preliminary diagnostic reports.
Aidoc wins FDA breakthrough designation for an AI system that analyzes chest X-rays and generates preliminary reports for over 100 findings.
Study in JAMA finds patient portal messages increased 153% between 2020 and 2025, with in-person visits also rising.
FDA withdraws warning letter to Whoop after the company revised its blood pressure feature to comply with wellness-device regulations.
FDA withdraws warning letter to Whoop after the company modified its blood pressure feature to comply with wellness-device requirements.
Democrats urge CMS for more transparency on WISeR, a Medicare AI prior-authorization pilot, citing concerns over care delays.
HHS announces reforms to accelerate early-stage clinical trials in the U.S., aiming to retain drug development amid competition with China.
Abbott launches its Instinct glucose sensor in European markets through MiniMed, expanding its continuous glucose monitoring portfolio abroad.
Ladder Health raises $7M seed round led by Nina Capital for virtual-first pediatric mental health delivery.
Abbott, PercuSense, and Biolinq executives discuss multi-analyte glucose sensor technology roadmaps.
Op-ed argues clinical AI models should reflect real-world healthcare disparities rather than assume equal access.
Joint Commission launches a new AI certification standard designed to scale governance from major health systems to small rural clinics.
Dexcom's Stelo OTC glucose sensor gains FDA clearance for children as young as two years old.
Medicare proposes closing a price-protection loophole for cancer immunotherapies switching from intravenous to subcutaneous delivery starting in 2029.
OIG report finds three largest Medicare Advantage insurers deny prior authorization requests for long-term acute care and inpatient rehab at elevated rates in 2024.
Healthcare executives argue that fragmented data infrastructure is a bottleneck to realizing value from AI investments.
CMS establishes an Office of Health Technology and Products to coordinate digital health initiatives.
DexCom, Abbott, and Insulet showcase upcoming diabetes management technologies at the ADA Scientific Sessions.
Abridge partners with Nvidia and Eli Lilly to build a foundation model for clinical conversations.
Abridge announces a Nvidia foundation model partnership, Eli Lilly investment, and expanded platform capabilities beyond clinical documentation.
House Appropriations Committee votes to block Medicare AI prior authorization pilot, citing delays in care to seniors.
Dexcom releases study data supporting glucose-sensor use for non-insulin-dependent Type 2 diabetes patients.
Vida Health and Instacart partner to provide grocery stipends for nutritious foods in cardiometabolic care programs.
DexCom and two other diabetes-care device makers presented clinical data at the American Diabetes Association Scientific Sessions.
2026 remote patient monitoring policy changes expand coverage while introducing operational complexity for health-tech providers.
DexCom acquires Nutrisense for continuous glucose monitoring integration; Insulet updates its patch pump software.
Microsoft and Mayo Clinic partner to develop a frontier AI model for healthcare applications.
MiniMed expands partnership with Abbott to develop a dual glucose-ketone sensor as part of its newly independent product roadmap.
Beth Israel Lahey Health demonstrates ambient AI reducing physician documentation burden during patient exams.
Novellia raises $18M Series A to expand its real-world data platform connecting patient records with pharmaceutical research.
Joint Commission launches voluntary AI responsibility certification for healthcare organizations deploying AI safely and ethically.
Signos raises $20M to scale glucose monitoring for weight loss using Dexcom's OTC CGM and AI-driven diet coaching.
CHAI releases AI governance guidance framework for health systems of all sizes.
AstraZeneca and Roche Diagnostics sign a three-year MOU to promote AI-powered digital pathology for breast and lung cancer across nine Asian markets.
Singapore's Ministry of Health commits SG$2.5B over five years for AI-driven preventive care and precision medicine research.
Teladoc Health integrates its virtual-care services into Walmart's Better Care Services platform.
CMS finalizes rule to streamline arbitration under the No Surprises Act, with mixed industry reception.
Oura Health launches a blood-pressure monitoring feature following an FDA policy change enabling real-time cardiovascular insights.
Philips partners with Disney to create an immersive ambient experience for children undergoing MRI scans.
Roy Schoenberg, Amwell co-founder, joins Amazon as head of its healthcare unit effective July 1.
Oura launches Ring 5 with stronger LED sensors, one-week battery life, and AI-enabled predictive health features.
Oura Health adds cuffless blood-pressure monitoring to its ring platform.
FDA relaxes wearables oversight, permitting wellness blood pressure and glucose sensors without premarket authorization; Oura Health accelerates feature roadmap.
Bayesian Health becomes first company to receive FDA clearance for continuous AI-powered sepsis monitoring.
Stem-cell engineered heart patches thickened weakened hearts and improved pumping ability in a small trial.
Abbott receives CE mark for a dual glucose-ketone sensor, expanding continuous monitoring capabilities.
Signos raises $20M for glucose monitoring and weight management; Dexcom leads round and establishes distribution partnership.
Analysis of security and data vulnerabilities in wearables-based remote patient monitoring programs.
Oura Health files for IPO as it expands from sleep tracking into broader healthcare applications.
Dexcom discovers two lots of scrap G7 sensors intended for destruction were resold to consumers instead.
DexCom identifies two lots of G7 glucose sensors that were stolen, resold, and used by customers.
Swoop acquires Nimble to expand its pharmacy connectivity and medication fulfillment capabilities.
J&J issues a controller correction for its Impella heart pump after a safety issue linked to 2 injuries and 1 death.
Remote patient monitoring technology faces challenges in delivering expected clinical and economic outcomes.
Ōura Health files for IPO following a $900M fundraise as it expands healthcare capabilities in its smart ring.
Ōura Health files for IPO following a $900M fundraise as it expands healthcare features on its smart ring.
A pediatric hospital system explores AI tools to reduce clinician burden from EHR systems and improve care delivery efficiency.
Hims & Hers launches generic semaglutide through its Canadian virtual care platform following Novo Nordisk's loss of patent protection.
Utah releases early data from a pilot program testing AI-driven prescription renewals for chronic-condition patients using Doctronic automation.
HHS deploys AI to audit state and federal grant recipients for fraud, with potential fund withholding for non-compliance.
Innovaccer acquires CaduceusHealth for $66M to strengthen its agentic RCM platform and address care denial losses.
Oura Health confidentially files for IPO following a $900M investment that valued the company at $11B.
Hong Kong advances a digital antimicrobial prescription tracking mandate requiring pharmacies and pharmaceutical traders to record dispensing electronically.
RFK Jr. fires two USPSTF vice chairs, drawing warnings from providers that the move could politicize preventive care guidelines.
The Path, an AI-powered mental wellness platform cofounded by Tony Robbins and former Calm leaders, raises $14.3M led by Prime Movers Lab.
Abridge appoints San Oo as technology chief amid expansion of health system partnerships.
House lawmakers explore Medicare physician pay reforms to counter consolidation of independent practices into health systems.
Whoop remains in dispute with the FDA over its blood pressure feature, which the agency flagged as a medical device in need of review.
Senate Democrats introduce a resolution to terminate Medicare's WISeR AI prior-authorization pilot, citing delays and care denials.
No Surprises Act arbitration is awarding out-of-network providers 24x in-network rates for spine procedures, inflating costs and favoring providers in 80% of disputes.
AI identified the root cause of an ultra-rare neonatal muscular disorder and a previously unknown treatment, enabling recovery.
Commure raises $70M led by General Catalyst, reaching a $7B post-money valuation.
Nourish closes a $100M Series C funding round led by Menlo Ventures for its virtual nutrition and metabolic care platform.
Dexcom CEO discusses potential future applications for continuous glucose monitoring sensors at STAT Breakthrough Summit West.
Vocal biomarkers enable multi-condition screening from a 40-second voice sample without labs or physical visits.
Nourish raises $100M in funding, reaching a $1.75B valuation for its virtual nutrition care platform.
Murdoch Children's Research Institute advances AI-powered infection detection on Apple Watch for children undergoing chemotherapy.
Employer and consumer groups urge the Trump administration to tighten oversight of the No Surprises Act's independent dispute resolution process.
Researchers at UC San Diego, Johns Hopkins, and UPMC develop ChatCPR, an AI tool that outperforms human 911 dispatchers in guiding CPR, released open-source.
CMS finalizes rules allowing ACA exchanges to offer bare-bones plans with fewer protections, raising consumer risk for high out-of-pocket costs.
CMS finalizes rule expanding access to catastrophic health plans on ACA exchanges starting 2027, broadening eligibility beyond current age limits.
Employers and unions petition the Trump administration to reform the No Surprises Act's dispute resolution process, citing arbiters' conflicts of interest and rising healthcare costs.
Real-world evidence is emerging as critical to bridging the gap between clinical trial outcomes and actual patient care in oncology.
Flinders University researchers argue AI diagnostic models should be evaluated on real-world patient outcomes rather than benchmark performance.
Anomaly raises $17M led by Sound Ventures for an AI-powered payer intelligence platform.
Australia commits A$598.3M over two years to expand My Health Record, including sharing-by-default system improvements and a new National Digital Child Health Record.
Shyld AI raises $13.4M for autonomous UV disinfection platform to reduce hospital-acquired infections and cleaning labor.
